Stay updated on Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3. This reflects a new release of the page’s software/content management update.SummaryDifference0.0%

- Check19 days agoChange DetectedFooter revision label updated to v3.6.2, replacing v3.6.0, indicating a site revision rather than changes to the study content.SummaryDifference0.0%

- Check33 days agoChange DetectedDifference0.3%

- Check41 days agoChange DetectedRevision indicator updated from v3.5.4 to v3.5.5, indicating a new page version. The change reflects a version update and does not alter the study details displayed.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the page's version rather than a substantive change to its content.SummaryDifference0.0%

- Check83 days agoChange DetectedThe page footer now shows an updated release/revision version (from v3.5.2 to v3.5.3) for the ClinicalTrials.gov interface.SummaryDifference0.0%

Stay in the know with updates to Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo with PD-(L)1 in Urothelial Carcinoma Clinical Trial page.